N-(6-(1-methyl-1H-pyrazol-4-yl)isoquinolin-3-yl)-1-(methylsulfonyl)piperidine-4-carboxamide

ID: ALA5285332

Max Phase: Preclinical

Molecular Formula: C20H23N5O3S

Molecular Weight: 413.50

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2ccc3cnc(NC(=O)C4CCN(S(C)(=O)=O)CC4)cc3c2)cn1

Standard InChI:  InChI=1S/C20H23N5O3S/c1-24-13-18(12-22-24)15-3-4-16-11-21-19(10-17(16)9-15)23-20(26)14-5-7-25(8-6-14)29(2,27)28/h3-4,9-14H,5-8H2,1-2H3,(H,21,23,26)

Standard InChI Key:  GXCOUFPTCZUTEE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -1.0729   -0.5621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583   -0.1498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3534   -0.5616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3534   -1.3869    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3565   -1.7987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0729   -1.3906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7885   -1.8031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5063   -1.3890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5081   -0.5646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7936   -0.1463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2227   -0.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9762   -0.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5281    0.1253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1157    0.8396    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3089    0.6681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3528    0.1253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0676   -0.1493    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7818   -0.5616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4960   -0.1493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4960    0.6752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2102    1.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9244    0.6752    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9244   -0.1493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2102   -0.5616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6386    1.0875    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.3528    0.6752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7818   -1.3864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0517    1.8031    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2262    1.8031    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  6  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
  1 10  1  0
 11  9  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 13 16  1  0
  3 17  1  0
 17 18  1  0
 18 19  1  0
 20 19  1  0
 21 20  1  0
 22 21  1  0
 23 22  1  0
 24 23  1  0
 19 24  1  0
 22 25  1  0
 25 26  1  0
 18 27  2  0
 25 28  2  0
 25 29  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA5285332

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 413.50

Molecular Weight (Monoisotopic): 413.1522

AlogP: 2.25

#Rotatable Bonds: 4

Polar Surface Area: 97.19

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.05

CX Basic pKa: 3.95

CX LogP: 0.86

CX LogD: 0.86

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.71

Np Likeness Score: -1.93

References

1. Lindberg MF, Deau E, Arfwedson J, George N, George P, Alfonso P, Corrionero A, Meijer L..  (2023)  Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases.,  66  (6): [PMID:36876904] [10.1021/acs.jmedchem.2c02068]

Source

Source(1):

• Scientific Literature